Ameriprise’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $56.2M | Buy |
702,031
+27,687
| +4% | +$2.28M | 0.01% | 815 |
|
|
2025
Q4 | $57.2M | Buy |
674,344
+63,217
| +10% | +$5.19M | 0.01% | 804 |
|
|
2025
Q3 | $47.3M | Sell |
611,127
-93,387
| -13% | -$7.3M | 0.01% | 917 |
|
|
2025
Q2 | $54.9M | Sell |
704,514
-50,523
| -7% | -$3.77M | 0.01% | 807 |
|
|
2025
Q1 | $54.6M | Sell |
755,037
-2,062
| -0.3% | -$148K | 0.01% | 798 |
|
|
2024
Q4 | $56.1M | Sell |
757,099
-1,332,490
| -64% | -$93.3M | 0.01% | 781 |
|
|
2024
Q3 | $138M | Sell |
2,089,589
-1,113,141
| -35% | -$80.9M | 0.04% | 440 |
|
|
2024
Q2 | $296M | Buy |
3,202,730
+747,771
| +30% | +$66.2M | 0.08% | 254 |
|
|
2024
Q1 | $236M | Buy |
2,454,959
+633,858
| +35% | +$53.2M | 0.06% | 303 |
|
|
2023
Q4 | $141M | Buy |
1,821,101
+136,290
| +8% | +$9.48M | 0.04% | 410 |
|
|
2023
Q3 | $115M | Sell |
1,684,811
-418,967
| -20% | -$33.7M | 0.04% | 438 |
|
|
2023
Q2 | $198M | Sell |
2,103,778
-96,130
| -4% | -$8.36M | 0.06% | 309 |
|
|
2023
Q1 | $182M | Buy |
2,199,908
+21,090
| +1% | +$1.66M | 0.06% | 319 |
|
|
2022
Q4 | $163M | Sell |
2,178,818
-1,237,435
| -36% | -$95.4M | 0.06% | 348 |
|
|
2022
Q3 | $283M | Sell |
3,416,253
-426,967
| -11% | -$41.1M | 0.1% | 213 |
|
|
2022
Q2 | $365M | Buy |
3,843,220
+873,155
| +29% | +$90.4M | 0.13% | 173 |
|
|
2022
Q1 | $348M | Buy |
2,970,065
+214,484
| +8% | +$24.1M | 0.1% | 217 |
|
|
2021
Q4 | $355M | Sell |
2,755,581
-551,182
| -17% | -$64.3M | 0.1% | 215 |
|
|
2021
Q3 | $374M | Sell |
3,306,763
-1,757,652
| -35% | -$201M | 0.12% | 188 |
|
|
2021
Q2 | $524M | Buy |
5,064,415
+33,525
| +0.7% | +$3.16M | 0.16% | 137 |
|
|
2021
Q1 | $421M | Buy |
5,030,890
+1,381,907
| +38% | +$117M | 0.14% | 159 |
|
|
2020
Q4 | $333M | Sell |
3,648,983
-174,265
| -5% | -$14.5M | 0.12% | 184 |
|
|
2020
Q3 | $305M | Sell |
3,823,248
-78,747
| -2% | -$6.14M | 0.12% | 179 |
|
|
2020
Q2 | $270M | Buy |
3,901,995
+418,782
| +12% | +$29.8M | 0.12% | 191 |
|
|
2020
Q1 | $219M | Sell |
3,483,213
-1,108,929
| -24% | -$80M | 0.11% | 188 |
|
|
2019
Q4 | $357M | Sell |
4,592,142
-455,433
| -9% | -$35.6M | 0.15% | 150 |
|
|
2019
Q3 | $370M | Sell |
5,047,575
-584,865
| -10% | -$41.1M | 0.17% | 126 |
|
|
2019
Q2 | $347M | Sell |
5,632,440
-115,677
| -2% | -$6.99M | 0.16% | 134 |
|
|
2019
Q1 | $367M | Sell |
5,748,117
-807,336
| -12% | -$46.1M | 0.17% | 125 |
|
|
2018
Q4 | $334M | Sell |
6,555,453
-173,178
| -3% | -$8.76M | 0.17% | 130 |
|
|
2018
Q3 | $390M | Sell |
6,728,631
-278,622
| -4% | -$13.6M | 0.14% | 171 |
|
|
2018
Q2 | $340M | Sell |
7,007,253
-1,726,065
| -20% | -$80.6M | 0.15% | 143 |
|
|
2018
Q1 | $406M | Sell |
8,733,318
-2,652,780
| -23% | -$115M | 0.18% | 120 |
|
|
2017
Q4 | $428M | Sell |
11,386,098
-1,308,327
| -10% | -$48M | 0.2% | 110 |
|
|
2017
Q3 | $463M | Sell |
12,694,425
-384,636
| -3% | -$14.7M | 0.22% | 100 |
|
|
2017
Q2 | $515M | Sell |
13,079,061
-4,133,316
| -24% | -$151M | 0.26% | 83 |
|
|
2017
Q1 | $540M | Buy |
17,212,377
+2,550,504
| +17% | +$79.9M | 0.28% | 77 |
|
|
2016
Q4 | $458M | Buy |
14,661,873
+1,700,064
| +13% | +$55.1M | 0.25% | 82 |
|
|
2016
Q3 | $521M | Buy |
12,961,809
+199,881
| +2% | +$7.53M | 0.29% | 72 |
|
|
2016
Q2 | $424M | Buy |
12,761,928
+4,897,701
| +62% | +$168M | 0.25% | 84 |
|
|
2016
Q1 | $231M | Buy |
7,864,227
+6,931,194
| +743% | +$191M | 0.14% | 160 |
|
|
2015
Q4 | $24.3M | Sell |
933,033
-53,931
| -5% | -$1.4M | 0.01% | 825 |
|
|
2015
Q3 | $23.2M | Buy |
986,964
+665,778
| +207% | +$16.1M | 0.01% | 840 |
|
|
2015
Q2 | $7.63M | Buy |
321,186
+44,850
| +16% | +$1.01M | ﹤0.01% | 1815 |
|
|
2015
Q1 | $6.53M | Sell |
276,336
-315,270
| -53% | -$7.07M | ﹤0.01% | 1920 |
|
|
2014
Q4 | $12.5M | Buy |
591,606
+233,652
| +65% | +$4.69M | 0.01% | 1315 |
|
|
2014
Q3 | $6.09M | Buy |
357,954
+136,812
| +62% | +$2.16M | ﹤0.01% | 1893 |
|
|
2014
Q2 | $3.16M | Sell |
221,142
-1,686
| -0.8% | -$22.9K | ﹤0.01% | 2326 |
|
|
2014
Q1 | $2.75M | Sell |
222,828
-101,628
| -31% | -$1.17M | ﹤0.01% | 2354 |
|
|
2013
Q4 | $3.56M | Sell |
324,456
-28,800
| -8% | -$325K | ﹤0.01% | 2200 |
|
|
2013
Q3 | $4.1M | Sell |
353,256
-28,472,250
| -99% | -$333M | ﹤0.01% | 2071 |
|
|
2013
Q2 | $323M | Buy |
+28,825,506
| New | +$341M | 0.22% | 98 |
|
Other funds holding EW
VCM
VPM
Ameriprise's EW Position: Q1 2026 in Review
Ameriprise increased its Edwards Lifesciences (EW) stake by 4.1% in Q1 2026, buying an estimated $2.28M and bringing the position to 702,031 shares worth $56.2M. The position accounts for 0.01% of the portfolio, ranked #815.
Ameriprise first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $540M in Q1 2017. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Ameriprise held 702,031 shares of Edwards Lifesciences worth $56.2M as of Q1 2026.
- Ameriprise bought 27,687 Edwards Lifesciences shares in Q1 2026, an estimated $2.28M.
- Edwards Lifesciences made up 0.01% of Ameriprise's portfolio in Q1 2026, its #815 holding.
- Ameriprise first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Edwards Lifesciences position peaked at $540M in Q1 2017.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.